Bluebird Bio
North America, Massachusetts, United States, Somerville
Description
Bluebird Bio is a biopharma company that develops and commercializes gene therapies for the treatment of severe genetic diseases and cancer.
Investor Profile
Bluebird Bio has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 100% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B rounds (top funding stages).
- Majority of deals are located in United Kingdom.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
Stage Focus
- Series B (100%)
Country Focus
- United Kingdom (100%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
